Betulinic acid inhibits the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis
- PMID: 30553912
- DOI: 10.1016/j.intimp.2018.11.042
Betulinic acid inhibits the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis
Abstract
The aggressive phenotype displayed by fibroblast-like synoviocytes (FLSs) contributes to cartilage and bone destruction in rheumatoid arthritis (RA). Betulinic acid has been demonstrated to have a positive therapeutic effect on tumor, inflammation and immune disorder, however, the effects of betulinic acid on RA FLSs have not been verified. Therefore, in the present study, we observed the effect of betulinic acid on the migration and invasion of RA FLSs and explored its underlying signal mechanisms. Our results showed that betulinic acid treatment suppressed the migration, invasion and reorganization of the actin cytoskeleton of RA FLSs. In addition, we found that the mRNA expression of IL-1β, IL-6, IL-8 and IL-17A were markedly down-regulated by treatment with betulinic acid in TNF-α-induced RA FLSs. To gain insight into the molecular mechanisms, we evaluated the effect of betulinic acid on NF-κB activation in RA FLSs. The results indicated that betulinic acid treatment reduced the TNF-α-induced activation of NF-κB signal pathway and the NF-κB nuclear accumulation. We also observed that treatment with betulinic acid attenuated synovial inflammation and joint destruction in mice with CIA. Taken together, these results suggest that betulinic acid inhibits the migration and invasion of RA FLSs by blocking NF-κB signal pathway activation.
Keywords: Betulinic acid; Fibroblast-like synoviocyte; Invasion; Migration; NF-κB; Rheumatoid arthritis.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Oxymatrine prevents synovial inflammation and migration via blocking NF-κB activation in rheumatoid fibroblast-like synoviocytes.Int Immunopharmacol. 2018 Feb;55:105-111. doi: 10.1016/j.intimp.2017.12.006. Epub 2017 Dec 22. Int Immunopharmacol. 2018. PMID: 29241159
-
Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway.Int Immunopharmacol. 2018 Feb;55:174-182. doi: 10.1016/j.intimp.2017.12.011. Epub 2017 Dec 22. Int Immunopharmacol. 2018. PMID: 29268189
-
Taraxasterol suppresses inflammation in IL-1β-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice.Int Immunopharmacol. 2019 May;70:274-283. doi: 10.1016/j.intimp.2019.02.029. Epub 2019 Mar 6. Int Immunopharmacol. 2019. PMID: 30851708
-
Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management.J Cell Mol Med. 2020 Nov;24(21):12234-12245. doi: 10.1111/jcmm.15803. Epub 2020 Sep 23. J Cell Mol Med. 2020. PMID: 32969153 Free PMC article. Review.
-
Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis.Int Immunopharmacol. 2023 Sep;122:110644. doi: 10.1016/j.intimp.2023.110644. Epub 2023 Jul 14. Int Immunopharmacol. 2023. PMID: 37454631 Review.
Cited by
-
Cold Air Plasma Inhibiting Tumor-Like Biological Behavior of Rheumatoid Arthritis Fibroblast-Like Synovial Cells via G2/M Cell Cycle Arrest.Open Access Rheumatol. 2024 May 14;16:75-85. doi: 10.2147/OARRR.S438536. eCollection 2024. Open Access Rheumatol. 2024. PMID: 38756916 Free PMC article.
-
Natural medicines of targeted rheumatoid arthritis and its action mechanism.Front Immunol. 2022 Aug 1;13:945129. doi: 10.3389/fimmu.2022.945129. eCollection 2022. Front Immunol. 2022. PMID: 35979373 Free PMC article. Review.
-
Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part II).Int J Mol Sci. 2022 Aug 10;23(16):8896. doi: 10.3390/ijms23168896. Int J Mol Sci. 2022. PMID: 36012159 Free PMC article. Review.
-
Betulinic Acid Ameliorates the T-2 Toxin-Triggered Intestinal Impairment in Mice by Inhibiting Inflammation and Mucosal Barrier Dysfunction through the NF-κB Signaling Pathway.Toxins (Basel). 2020 Dec 13;12(12):794. doi: 10.3390/toxins12120794. Toxins (Basel). 2020. PMID: 33322178 Free PMC article.
-
A clickable photoaffinity probe of betulinic acid identifies tropomyosin as a target.Acta Pharm Sin B. 2022 May;12(5):2406-2416. doi: 10.1016/j.apsb.2021.12.008. Epub 2021 Dec 22. Acta Pharm Sin B. 2022. PMID: 35646545 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical